Abstract
| Original language | English |
|---|---|
| Article number | 6 |
| Journal | Frontiers in Genetics |
| Volume | 5 |
| Issue number | JAN |
| DOIs | |
| State | Published - 2015 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Genetics
- Molecular Medicine
- Genetics(clinical)
Cite this
Genetics of kidney disease and related cardiometabolic phenotypes in Zuni Indians : The Zuni Kidney Project. / Laston, Sandra L.; Voruganti, V. Saroja; Haack, Karin; Shah, Vallabh O.; Bobelu, Arlene; Bobelu, Jeanette; Ghahate, Donica; Harford, Antonia M.; Paine, Susan S.; Tentori, Francesca; Cole, Shelley A.; MacCluer, Jean W.; Comuzzie, Anthony G.; Zager, Philip G.
In: Frontiers in Genetics, Vol. 5, No. JAN, 6, 2015.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Genetics of kidney disease and related cardiometabolic phenotypes in Zuni Indians
T2 - The Zuni Kidney Project
AU - Laston, Sandra L.
AU - Voruganti, V. Saroja
AU - Haack, Karin
AU - Shah, Vallabh O.
AU - Bobelu, Arlene
AU - Bobelu, Jeanette
AU - Ghahate, Donica
AU - Harford, Antonia M.
AU - Paine, Susan S.
AU - Tentori, Francesca
AU - Cole, Shelley A.
AU - MacCluer, Jean W.
AU - Comuzzie, Anthony G.
AU - Zager, Philip G.
PY - 2015
Y1 - 2015
N2 - The objective of this study is to identify genetic factors associated with chronic kidney disease (CKD) and related cardiometabolic phenotypes among participants of the Genetics of Kidney Disease in Zuni Indians study. The study was conducted as a community-based participatory research project in the Zuni Indians, a small endogamous tribe in rural New Mexico. We recruited 998 members from 28 extended multigenerational families, ascertained through probands with CKD who had at least one sibling with CKD. We used the Illumina Infinium Human1M-Duo version 3.0 BeadChips to type 1.1 million single nucleotide polymorphisms (SNPs). Prevalence estimates for CKD, hyperuricemia, diabetes, and hypertension were 24%, 30%, 17% and 34%, respectively. We found a significant (p < 1.58 × 10-7) association for a SNP in a novel gene for serum creatinine (PTPLAD2). We replicated significant associations for genes with serum uric acid (SLC2A9), triglyceride levels (APOA1, BUD13, ZNF259), and total cholesterol (PVRL2). We found novel suggestive associations (p < 1.58 × 10-6) for SNPs in genes with systolic (OLFML2B), and diastolic blood pressure (NFIA). We identified a series of genes associated with CKD and related cardiometabolic phenotypes among Zuni Indians, a population with a high prevalence of kidney disease. Illuminating genetic variations that modulate the risk for these disorders may ultimately provide a basis for novel preventive strategies and therapeutic interventions.
AB - The objective of this study is to identify genetic factors associated with chronic kidney disease (CKD) and related cardiometabolic phenotypes among participants of the Genetics of Kidney Disease in Zuni Indians study. The study was conducted as a community-based participatory research project in the Zuni Indians, a small endogamous tribe in rural New Mexico. We recruited 998 members from 28 extended multigenerational families, ascertained through probands with CKD who had at least one sibling with CKD. We used the Illumina Infinium Human1M-Duo version 3.0 BeadChips to type 1.1 million single nucleotide polymorphisms (SNPs). Prevalence estimates for CKD, hyperuricemia, diabetes, and hypertension were 24%, 30%, 17% and 34%, respectively. We found a significant (p < 1.58 × 10-7) association for a SNP in a novel gene for serum creatinine (PTPLAD2). We replicated significant associations for genes with serum uric acid (SLC2A9), triglyceride levels (APOA1, BUD13, ZNF259), and total cholesterol (PVRL2). We found novel suggestive associations (p < 1.58 × 10-6) for SNPs in genes with systolic (OLFML2B), and diastolic blood pressure (NFIA). We identified a series of genes associated with CKD and related cardiometabolic phenotypes among Zuni Indians, a population with a high prevalence of kidney disease. Illuminating genetic variations that modulate the risk for these disorders may ultimately provide a basis for novel preventive strategies and therapeutic interventions.
KW - Association
KW - Kidney function
KW - Serum uric acid
KW - Single nucleotide polymorphisms
KW - Triglycerides
UR - http://www.scopus.com/inward/record.url?scp=84923172275&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84923172275&partnerID=8YFLogxK
U2 - 10.3389/fgene.2015.00006
DO - 10.3389/fgene.2015.00006
M3 - Article
AN - SCOPUS:84923172275
VL - 5
JO - Frontiers in Genetics
JF - Frontiers in Genetics
SN - 1664-8021
IS - JAN
M1 - 6
ER -